TELA Bio Inc. (TELA) Prices 3M Share Common Offering at $16/Sh

TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced the pricing of its underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $16.00 per share for gross proceeds of $48.0 million, before underwriting discounts and commissions. In addition, TELA has granted the underwriters a 30-day option to purchase up to 450,000 additional shares of common stock in the offering. All shares of common stock are being offered by TELA. The offering is expected to close on June 30, 2020, subject to the satisfaction of customary closing conditions.

Jefferies LLC and Piper Sandler & Co. are acting as joint book-running managers for the offering. Canaccord Genuity LLC is acting as lead manager and JMP Securities LLC is acting as co-manager.

You May Also Be Interested In

• SharonAI Holdings (SHAZ) files for 8.02M share offering by selling stockholders
• Jefferies on Pony AI Inc (PONY): 'overseas expansion is increasingly shifting toward JDM'
• Jefferies Downgrades Pediatrix Medical Group (MD) to Hold